ID18666A - Penggunaan komposisi komposisi yang terdiri dari senyawa senyawa stabil yang efektif secara biologi - Google Patents

Penggunaan komposisi komposisi yang terdiri dari senyawa senyawa stabil yang efektif secara biologi

Info

Publication number
ID18666A
ID18666A IDP970303A ID970303A ID18666A ID 18666 A ID18666 A ID 18666A ID P970303 A IDP970303 A ID P970303A ID 970303 A ID970303 A ID 970303A ID 18666 A ID18666 A ID 18666A
Authority
ID
Indonesia
Prior art keywords
composition
effectively
stable compound
consist
biological stable
Prior art date
Application number
IDP970303A
Other languages
English (en)
Indonesian (id)
Inventor
Luppo Edens
Hong Sheng Tan
Johannes Wilhelmus Jac Lambers
Original Assignee
Gist Brocades Bv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=27443289&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ID18666(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Gist Brocades Bv filed Critical Gist Brocades Bv
Publication of ID18666A publication Critical patent/ID18666A/id

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B05—SPRAYING OR ATOMISING IN GENERAL; APPLYING FLUENT MATERIALS TO SURFACES, IN GENERAL
    • B05B—SPRAYING APPARATUS; ATOMISING APPARATUS; NOZZLES
    • B05B11/00—Single-unit hand-held apparatus in which flow of contents is produced by the muscular force of the operator at the moment of use
    • B05B11/01—Single-unit hand-held apparatus in which flow of contents is produced by the muscular force of the operator at the moment of use characterised by the means producing the flow
    • B05B11/10—Pump arrangements for transferring the contents from the container to a pump chamber by a sucking effect and forcing the contents out through the dispensing nozzle
    • B05B11/1081—Arrangements for pumping several liquids or other fluent materials from several containers, e.g. for mixing them at the moment of pumping
    • B05B11/1084—Arrangements for pumping several liquids or other fluent materials from several containers, e.g. for mixing them at the moment of pumping each liquid or other fluent material being pumped by a separate pump

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Dispersion Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Dermatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Preparation (AREA)
  • Cosmetics (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
IDP970303A 1996-01-31 1997-01-31 Penggunaan komposisi komposisi yang terdiri dari senyawa senyawa stabil yang efektif secara biologi ID18666A (id)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
EP96200190 1996-01-31
EP96200594 1996-03-08
EP96201713 1996-06-21
EP96202781 1996-10-03

Publications (1)

Publication Number Publication Date
ID18666A true ID18666A (id) 1998-04-30

Family

ID=27443289

Family Applications (1)

Application Number Title Priority Date Filing Date
IDP970303A ID18666A (id) 1996-01-31 1997-01-31 Penggunaan komposisi komposisi yang terdiri dari senyawa senyawa stabil yang efektif secara biologi

Country Status (16)

Country Link
US (1) US6117433A (zh)
EP (1) EP0817613B1 (zh)
JP (1) JPH11503465A (zh)
KR (1) KR100517060B1 (zh)
CN (1) CN1140261C (zh)
AR (1) AR006308A1 (zh)
AT (1) ATE291897T1 (zh)
AU (1) AU1721697A (zh)
BR (1) BR9702049B1 (zh)
CA (1) CA2216169C (zh)
DE (1) DE69732881T2 (zh)
ES (1) ES2237789T3 (zh)
ID (1) ID18666A (zh)
MX (1) MX9707487A (zh)
PT (1) PT817613E (zh)
WO (1) WO1997027841A1 (zh)

Families Citing this family (71)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5947335A (en) * 1996-10-15 1999-09-07 Lever Brothers Company Dual compartment package
US6082588A (en) * 1997-01-10 2000-07-04 Lever Brothers Company, Division Of Conopco, Inc. Dual compartment package and pumps
US6448233B1 (en) 1997-07-08 2002-09-10 Cosmoferm B.V. Topical application of a combination of benzoyl peroxide and a second active ingredient
KR100351620B1 (ko) * 1999-07-09 2002-09-10 주식회사대성미생물연구소 3차 결정구조의 내열성 효소
KR100340086B1 (ko) * 1999-08-27 2002-06-12 안용찬 비듬방지용 샴푸조성물
US6585984B1 (en) * 2000-03-03 2003-07-01 Unilever Home & Personal Care Usa, Division Of Conopco, Inc. Dual composition cosmetic product with a concentration sensitive and an incompatible active respectively placed within first and second compositions
AU2001255487A1 (en) * 2000-04-21 2001-11-07 Nature's Cure Salicylic acid acne spray formulations and methods for treating acne with same
US20030206897A1 (en) * 2000-09-13 2003-11-06 The Procter & Gamble Company Cosmetic compositions
EP1317247A1 (en) * 2000-09-13 2003-06-11 The Procter & Gamble Company Cosmetic method for treatment of skin and/or hair
WO2002022101A1 (en) * 2000-09-13 2002-03-21 The Procter & Gamble Company Cosmetic method
WO2002022103A1 (en) * 2000-09-13 2002-03-21 The Procter & Gamble Company Cosmetic compositions
WO2002022102A1 (en) * 2000-09-13 2002-03-21 The Procter & Gamble Company Cosmetic compositions
JP2004508391A (ja) * 2000-09-13 2004-03-18 ザ、プロクター、エンド、ギャンブル、カンパニー 化粧方法
JP2002326924A (ja) * 2001-05-07 2002-11-15 Hayashibara Biochem Lab Inc 洗顔料
US7364565B2 (en) * 2001-07-27 2008-04-29 Ramot At Tel Aviv University Ltd. Controlled enzymatic removal and retrieval of cells
GB0126433D0 (en) * 2001-11-03 2002-01-02 Astrazeneca Ab Compounds
US20050043336A1 (en) * 2001-11-03 2005-02-24 Hennequin Laurent Francois Andre Quinazoline derivatives as antitumor agents
US20080152613A1 (en) * 2002-01-31 2008-06-26 Norburn Robert B Method for manufacturing a skin care composition
CA2416305A1 (en) * 2002-01-31 2003-07-31 Davies, John Shaving, after-shave, and skin conditioning compositions
US20080152722A1 (en) * 2002-01-31 2008-06-26 Norburn Robert B Skin care composition
TWI324597B (en) * 2002-03-28 2010-05-11 Astrazeneca Ab Quinazoline derivatives
US6924285B2 (en) 2002-03-30 2005-08-02 Boehringer Ingelheim Pharma Gmbh & Co. Bicyclic heterocyclic compounds, pharmaceutical compositions containing these compounds, their use and process for preparing them
FR2840215B1 (fr) * 2002-06-03 2004-08-27 Oreal Composition contenant un actif susceptible d'etre oxyde par un hydroperoxyde, une lipoxygenase et un substrat et procede mettant en oeuvre cette composition
DE10241073A1 (de) * 2002-09-05 2004-03-11 Beiersdorf Ag Kosmetikum mit aktivierbaren Pflegekomponenten
GB0309009D0 (en) * 2003-04-22 2003-05-28 Astrazeneca Ab Quinazoline derivatives
GB0309850D0 (en) * 2003-04-30 2003-06-04 Astrazeneca Ab Quinazoline derivatives
ATE446969T1 (de) * 2003-08-20 2009-11-15 Seikagaku Kogyo Co Ltd Stabilisierungsmittel für enzyme
DE10342211A1 (de) * 2003-09-12 2005-04-07 Beiersdorf Ag Kosmetikum
GB0321648D0 (en) * 2003-09-16 2003-10-15 Astrazeneca Ab Quinazoline derivatives
US20070032508A1 (en) * 2003-09-16 2007-02-08 Bradbury Robert H Quinazoline derivatives as tyrosine kinase inhibitors
CN1882569B (zh) * 2003-09-19 2010-09-29 阿斯利康(瑞典)有限公司 喹唑啉衍生物
US20070037837A1 (en) * 2003-09-19 2007-02-15 Hennequin Laurent Francois A Quinazoline derivatives
JP2007506716A (ja) * 2003-09-25 2007-03-22 アストラゼネカ アクチボラグ キナゾリン誘導体
EP1669139B1 (en) * 2003-10-03 2012-03-07 Kao Corporation Discharge device
PL1673057T3 (pl) * 2003-10-10 2009-10-30 Cosmedical Aps Inhibicja wzrostu włosów
EP1677747A1 (en) * 2003-10-31 2006-07-12 The Procter & Gamble Company Method of providing a blended composition
GB0326459D0 (en) * 2003-11-13 2003-12-17 Astrazeneca Ab Quinazoline derivatives
MXPA06014125A (es) * 2004-06-04 2007-01-31 Astrazeneca Ab Derivados de quinazolina en la forma de cinasas de tirosina de receptor erbb.
JP2005350384A (ja) * 2004-06-09 2005-12-22 Blc:Kk 基礎化粧方法
ES2479515T3 (es) 2004-07-26 2014-07-24 Merz Pharma Gmbh & Co. Kgaa Composición terapéutica con una neurotoxina botulínica
ATE501148T1 (de) 2004-12-14 2011-03-15 Astrazeneca Ab Pyrazolopyrimidinverbindungen als antitumormittel
AR055564A1 (es) * 2005-02-26 2007-08-22 Astrazeneca Ab Derivados de quinazolina
GB0504474D0 (en) * 2005-03-04 2005-04-13 Astrazeneca Ab Chemical compounds
GB0508717D0 (en) * 2005-04-29 2005-06-08 Astrazeneca Ab Chemical compounds
GB0508715D0 (en) * 2005-04-29 2005-06-08 Astrazeneca Ab Chemical compounds
US7378084B2 (en) * 2005-07-01 2008-05-27 Playtex Products, Inc. Sunless tanning composition and method of sunless tanning
WO2007017875A2 (en) * 2005-08-10 2007-02-15 Maya-Biotech Ltd. Drug delivery system for topical administration
WO2007034143A1 (en) * 2005-09-20 2007-03-29 Astrazeneca Ab Quinazoline derivatives as anticancer agents
WO2007034144A1 (en) * 2005-09-20 2007-03-29 Astrazeneca Ab 4- (ih-indazol-s-yl-amino)-quinazoline compounds as erbb receptor tyrosine kinase inhibitors for the treatment of cancer
EP1960371B1 (en) * 2005-12-02 2009-09-16 AstraZeneca AB Quinazoleine derivatives used as inhibitors of erbb tyrosine kinase
JP2009517450A (ja) * 2005-12-02 2009-04-30 アストラゼネカ アクチボラグ チロシンキナーゼ阻害薬としての４−アニリノ置換キナゾリン誘導体
EP1921070A1 (de) * 2006-11-10 2008-05-14 Boehringer Ingelheim Pharma GmbH & Co. KG Bicyclische Heterocyclen, diese Verbindungen enthaltende Arzneimittel, deren Verwendung und Verfahren zu ihrer Herstelllung
KR20090116782A (ko) * 2007-02-06 2009-11-11 베링거 인겔하임 인터내셔날 게엠베하 바이사이클릭 헤테로사이클, 당해 화합물을 함유하는 약물, 이의 용도 및 이의 제조방법
US8569221B2 (en) * 2007-08-30 2013-10-29 Kimberly-Clark Worldwide, Inc. Stain-discharging and removing system
KR20100111291A (ko) 2008-02-07 2010-10-14 베링거 인겔하임 인터내셔날 게엠베하 스피로사이클릭 헤테로사이클, 상기 화합물을 함유하는 약제, 이의 용도 및 이의 제조 방법
US8088782B2 (en) * 2008-05-13 2012-01-03 Astrazeneca Ab Crystalline 4-(3-chloro-2-fluoroanilino)-7 methoxy-6-{[1-(N-methylcarbamoylmethyl)piperidin-4-yl]oxy}quinazoline difumarate form A
US8648191B2 (en) * 2008-08-08 2014-02-11 Boehringer Ingelheim International Gmbh Cyclohexyloxy substituted heterocycles, pharmaceutical compositions containing these compounds and processes for preparing them
US20120070390A1 (en) * 2010-04-21 2012-03-22 Phillips D Howard Topical drug delivery system with dual carriers
PL2729220T3 (pl) 2011-12-20 2016-05-31 Oriflame Res And Development Ltd Związki o aktywnościach przeciwstarzeniowych
US9931657B2 (en) * 2014-04-18 2018-04-03 The Clorox Company Dual chamber spray dispenser with a single delivery tube
CN107177567B (zh) * 2016-02-16 2018-07-03 上海青瑞食品科技有限公司 一种液体酶制剂及制备方法
EP3210596A1 (en) 2016-02-29 2017-08-30 G.L. Pharma GmbH Abuse-deterrent pharmaceutical composition
EP3210630A1 (en) 2016-02-29 2017-08-30 G.L. Pharma GmbH Abuse-deterrent pharmaceutical compositions
EP3231420A1 (en) 2016-02-29 2017-10-18 G.L. Pharma GmbH Abuse-deterrent pharmaceutical compositions
FR3052035B1 (fr) 2016-06-02 2020-10-09 Oreal Systeme de distribution d'un produit cosmetique
KR102388005B1 (ko) 2017-03-27 2022-04-18 에보닉 오퍼레이션스 게엠베하 세라마이드를 함유하는 제형을 제조하기 위한 방법 및 제품
CN110475538B (zh) * 2017-03-31 2022-08-12 株式会社爱茉莉太平洋 提高穗花杉双黄酮稳定性的透明或半透明化妆品组合物
WO2018195415A1 (en) * 2017-04-21 2018-10-25 Phi Therapeutics, Inc. Compositions comprising propionibacterium acnes bacteriophages for treating acne
IT201900006994A1 (it) * 2019-05-20 2020-11-20 Biodermol Ambiente S R L Ceppi batterici per uso industriale
JP2023503910A (ja) * 2019-11-22 2023-02-01 サムヤン ホールディングス コーポレイション 薬物送達用ナノ粒子組成物製造用キット
KR20230029260A (ko) * 2021-08-24 2023-03-03 (주)아모레퍼시픽 효소 손상을 방지하는 화장료 조성물 및 이를 저장하는 화장품 용기

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR6318M (zh) * 1967-04-04 1968-09-23
FR2032202A5 (zh) * 1969-02-21 1970-11-20 Oreal
US3834075A (en) * 1973-02-12 1974-09-10 Tre X Injector Syst Co Tree trunk pressure feeding device
US3992813A (en) * 1975-07-07 1976-11-23 Freshel David C Tree treating system
US4243543A (en) * 1979-05-11 1981-01-06 Economics Laboratory, Inc. Stabilized liquid enzyme-containing detergent compositions
US4556554A (en) * 1981-06-01 1985-12-03 Germaine Monteil Cosmetiques Corp. Immobilized enzymes
AU3667189A (en) * 1988-06-23 1990-01-04 Unilever Plc Enzyme-containing liquid detergents
US4959179A (en) * 1989-01-30 1990-09-25 Lever Brothers Company Stabilized enzymes liquid detergent composition containing lipase and protease
WO1991000094A1 (en) * 1989-06-28 1991-01-10 Finn Tranberg A new papaverine injection system
EP0506791B1 (en) * 1989-12-21 1993-09-08 Novo Nordisk A/S Enzyme containing preparation and detergent containing such preparation
DE4023601A1 (de) * 1990-07-25 1992-01-30 Henkel Kgaa Fluessige enzymzubereitung
DE4121820A1 (de) * 1991-07-02 1993-01-07 Basf Ag Mikrokapseldispersionen
TW203552B (en) * 1992-02-18 1993-04-11 J Baroody Lloyd Compositions of clindamycin and benzoyl peroxide for acne treatment
US5252312A (en) * 1992-09-30 1993-10-12 Chesebrough-Pond's Usa Co., Division Of Conopco, Inc. Package effervescible composition
JP2866741B2 (ja) * 1993-03-31 1999-03-08 シェリング−プラウ・ヘルスケア・プロダクツ・インコーポレーテッド 日光なし日焼けのための方法と装置
PT731834E (pt) * 1993-12-03 2000-09-29 Buckman Labor Inc Estabilizacao de enzimas por copolimeros em bloco
US5843409A (en) * 1994-08-08 1998-12-01 Colgate Palmolive Company Two component dentifrice for the treatment of dentinal hypersensitivity
FR2725897B1 (fr) * 1994-10-24 1996-12-06 Oreal Produit pour application topique contenant une lipase et un precurseur d'actif

Also Published As

Publication number Publication date
CN1140261C (zh) 2004-03-03
MX9707487A (es) 1997-11-29
EP0817613A1 (en) 1998-01-14
EP0817613B1 (en) 2005-03-30
CA2216169A1 (en) 1997-08-07
CA2216169C (en) 2007-01-23
CN1178460A (zh) 1998-04-08
BR9702049A (pt) 1998-01-13
DE69732881D1 (de) 2005-05-04
PT817613E (pt) 2005-06-30
ATE291897T1 (de) 2005-04-15
KR19980703467A (ko) 1998-11-05
US6117433A (en) 2000-09-12
KR100517060B1 (ko) 2006-05-25
AR006308A1 (es) 1999-08-25
JPH11503465A (ja) 1999-03-26
BR9702049B1 (pt) 2010-08-10
WO1997027841A1 (en) 1997-08-07
AU1721697A (en) 1997-08-22
ES2237789T3 (es) 2005-08-01
DE69732881T2 (de) 2006-04-06

Similar Documents

Publication Publication Date Title
ID18666A (id) Penggunaan komposisi komposisi yang terdiri dari senyawa senyawa stabil yang efektif secara biologi
ID24915A (id) Komposisi kosmetik yang stabil
ID24310A (id) Formulasi-formulasi insulin yang stabil
ID16926A (id) Komposisi-komposisi antijamur dengan ketersediaan biologis yang lebih baik
BR9509873A (pt) Formulações parasiticidas adequadas para aplicação dérmica
MA24466A1 (fr) Compositions contenant de la tetrahydrolistatine
HUP9802865A3 (en) N-(substituted phenyl)-pyrazole-derivatives, preparation and use thereof, parasiticidal compositions containing these compounds as active ingredients
IS2325B (is) Örgerðar samsetningar epleróns
HUP0000575A3 (en) Novel formulation comprising budesonid as active indegredient
ATE210720T1 (de) Verdickte saure zusammensetzung
DE69823360D1 (de) Feste arzneizubereitung enthaltend benzofuranderivate
DE69825607D1 (de) Verminderung des haarwuchses
DE59910836D1 (de) Dermal applizierbare wasserhaltige formulierungen von parasitiziden
ATE357237T1 (de) Formulierungen enthaltend cefuroxim-axetil
NZ318391A (en) Fungicidal compositions comprising fenazaquine as an active substance
ID18832A (id) Komposisi insektisida
TR199903132A3 (tr) Metalosan bilesiklerinin aktive edici kompozisyonu.
ID22060A (id) Senyawa-senyawa 2-imidazolinilaminobenzoksazol berguna sebagai agonis adrenoseptor
ID29966A (id) Sulfoniloksazolamina-sulfoniloksazolamina sebagai senyawa-senyawa aktif terapi
HUP9700983A3 (en) 1,4-diaryl-2-fluoro-2-butene derivatives, intermediates, preparation and use thereof, insecticide and acaricide compositions containing these compounds as active ingredients
FR2767062B1 (fr) Composition comprenant de la propolis
PL316306A1 (en) Insecticidal composition of active substances
HUP9901104A3 (en) Pyrazole-4-yl-hetaroyl derivatives, preparation and use thereof, herbicide compositions containing these compounds as active ingredients
EP1011689B8 (en) USE OF 9a-AZALIDES AS VETERINARY ANTIMICROBIAL AGENTS
ATE227733T1 (de) Herstellung von avermectin-verbindungen